Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
Open Access
- 24 March 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 156 (3), 542-551
- https://doi.org/10.1111/j.1365-2249.2009.03924.x
Abstract
Recent reports show that 5-amino-4-imidazole carboxamide riboside (AICAR), a pharmacological activator of AMP-activated protein kinase (AMPK), inhibits the lipopolysaccharide (LPS)-induced production of proinflammatory cytokines. MRL/MPJ-Faslpr (MRL/lpr) mice show an intrinsic decreased threshold for the production of inflammatory mediators when stimulated. In our current studies, we sought to determine if AMPK activation would inhibit inflammatory mediator production in stimulated kidney mesangial cells. Cultured mesangial cells from MRL/lpr mice were treated with AICAR and stimulated with LPS/interferon (IFN)-γ. AICAR decreased dose-dependently inducible nitric oxide synthase (iNOS), cyclooxygenase-2 and interleukin-6 production in LPS/IFN-γ-stimulated mesangial cells. Mechanistically, AICAR inhibited the LPS/IFN-γ-stimulated PI3K/Akt signalling inflammatory cascade but did not affect LPS/IFN-γ-mediated inhibitory kappa B phosphorylation or nuclear factor (NF)-κB (p65) nuclear translocation. Treatment with the adenosine kinase inhibitor 5′-iodotubercidin blocked the ability of AICAR to activate AMPK and prevented AICAR from inhibiting the LPS/IFN-γ-stimulated PI3K/Akt pathway and attenuating iNOS expression. Taken together, these observations suggest that AICAR inhibits LPS/IFN-γ-induced Akt phosphorylation through AMPK activation and may serve as a potential therapeutic target in inflammatory diseases.This publication has 56 references indexed in Scilit:
- Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cellsExperimental Cell Research, 2007
- Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesityChemico-Biological Interactions, 2007
- AMP‐activated protein kinase – development of the energy sensor conceptJournal Of Physiology-London, 2006
- Adenosine Inhibits PDGF-Induced Growth of Human Glomerular Mesangial Cells Via A 2B ReceptorsHypertension, 2005
- 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-α production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophagesBiochemical and Biophysical Research Communications, 2004
- Differential regulation of phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced oxidative stress in the kidney of young and old ratsBiochemical and Biophysical Research Communications, 2004
- 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein KinaseJournal of Neuroscience, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Effects of Stimulation of AMP-activated Protein Kinase on Insulin-like Growth Factor 1- and Epidermal Growth Factor-dependent Extracellular Signal-regulated Kinase PathwayPublished by Elsevier BV ,2001
- Prostaglandin J2 Inhibition of Mesangial Cell iNOS ExpressionClinical Immunology, 2001